|
|
|
Insider
Information: |
Edelman Joseph |
Relationship: |
Former 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
42 |
|
Direct
Shares |
630,171 |
|
Indirect Shares
|
332,164,708 |
|
|
Direct
Value |
$1,272,417 |
|
|
Indirect Value
|
$2,785,272,304 |
|
|
Total
Shares |
332,794,879 |
|
|
Total
Value |
$2,786,544,721 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
79
|
21
|
Stock
price went up :
|
50
|
11
|
Stock
price went down : |
29
|
10
|
|
|
|
Gain/Loss Ratio : |
1.7
|
1.1
|
Percentage
Gain/Loss : |
11.5%
|
171.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2008-06-23 |
0 |
2008-06-23 |
6,387,546 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
10% Owner |
|
0 |
2011-11-02 |
0 |
Premium* |
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
10% Owner |
2012-11-01 |
133,133 |
2012-11-29 |
2,595,293 |
Premium* |
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
|
0 |
2017-06-19 |
4,533,728 |
Premium* |
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
|
0 |
2018-10-03 |
20,724,424 |
Premium* |
|
VBI Vaccines Inc |
VBIV |
10% Owner |
|
0 |
2014-07-25 |
2,610,356 |
Premium* |
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
|
0 |
2024-04-05 |
9,275,851 |
Premium* |
|
Aravive Inc |
ARAV |
10% Owner |
|
0 |
2017-09-22 |
2,099,563 |
Premium* |
|
Kadmon Holdings, Llc |
KDMN |
10% Owner |
|
0 |
2019-11-18 |
14,636,334 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2017-09-29 |
0 |
2018-08-10 |
4,070,357 |
Premium* |
|
Global Blood Therapeutics, Inc. |
GBT |
10% Owner |
2017-12-19 |
0 |
2017-12-19 |
4,889,066 |
Premium* |
|
Corium International, Inc. |
CORI |
10% Owner |
2018-01-16 |
0 |
2018-10-12 |
2,724,686 |
Premium* |
|
Albireo Pharma Inc |
ALBO |
10% Owner |
2018-01-25 |
0 |
2022-10-13 |
1,939,723 |
Premium* |
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
2018-01-30 |
0 |
2024-01-11 |
6,906,646 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
10% Owner |
2018-02-13 |
0 |
2019-01-08 |
2,253,376 |
Premium* |
|
Motus Gi Holdings Inc |
MOTS |
10% Owner |
2018-02-16 |
0 |
2021-01-22 |
2,660,542 |
Premium* |
|
Quotient Ltd |
QTNTQ |
10% Owner |
2018-05-22 |
0 |
2022-10-31 |
7,945,211 |
Premium* |
|
Dova Pharmaceuticals, Inc. |
DOVA |
10% Owner |
2018-06-04 |
0 |
2019-11-12 |
0 |
Premium* |
|
Meiragtx Holdings Plc |
MGTX |
10% Owner |
2018-06-08 |
0 |
2023-05-05 |
11,281,103 |
Premium* |
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
10% Owner |
2018-07-20 |
0 |
2022-04-18 |
5,321,032 |
Premium* |
|
Agile Therapeutics Inc |
AGRX |
10% Owner |
2018-07-26 |
0 |
2021-10-13 |
21,654,485 |
Premium* |
|
Verrica Pharmaceuticals Inc. |
VRCA |
10% Owner |
2018-06-19 |
0 |
2023-12-29 |
7,099,182 |
Premium* |
|
Athenex, Inc. |
ATNX |
10% Owner |
2019-05-06 |
0 |
2020-09-14 |
13,532,467 |
Premium* |
|
ADMA Biologics Inc |
ADMA |
10% Owner |
2019-05-21 |
0 |
2021-09-30 |
13,262,375 |
Premium* |
|
Foamix Pharmaceuticals Ltd |
FOMX |
10% Owner |
|
0 |
2019-07-29 |
11,203,881 |
Premium* |
|
Lyra Therapeutics, Inc. |
LYRA |
Director, 10% Owner |
2020-05-05 |
0 |
2023-05-31 |
12,757,563 |
Premium* |
|
VYNE Therapeutics Inc |
VYNE |
10% Owner |
2020-06-09 |
0 |
2021-08-16 |
4,935,057 |
Premium* |
|
Leap Therapeutics, Inc. |
LPTX |
10% Owner |
2020-06-22 |
0 |
2020-06-22 |
8,476,496 |
Premium* |
|
Athira Pharma, Inc. |
ATHA |
Director, 10% Owner |
|
0 |
2023-12-29 |
5,402,964 |
Premium* |
|
Cerevel Therapeutics Holdings, I... |
CERE |
Director |
2020-10-20 |
0 |
2024-02-20 |
10,794,876 |
Premium* |
|
Scynexis Inc |
SCYX |
10% Owner |
2021-01-20 |
0 |
2021-01-22 |
1,800,000 |
Premium* |
|
Landos Biopharma, Inc. |
LABP |
Director, 10% Owner |
|
0 |
2021-02-09 |
17,960,839 |
Premium* |
|
Astria Therapeutics, Inc |
ATXS |
Director |
|
0 |
2024-02-01 |
6,485,420 |
Premium* |
|
Prometheus Biosciences, Inc. |
RXDX |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
3,314,032 |
Premium* |
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2021-04-27 |
0 |
2021-10-12 |
2,487,019 |
Premium* |
|
Nautilus Biotechnology, Inc |
NAUT |
10% Owner |
2021-05-24 |
497,038 |
2021-12-08 |
9,111,151 |
Premium* |
|
Isoplexis Corp |
ISO |
10% Owner |
2021-10-12 |
0 |
2021-10-12 |
3,554,587 |
Premium* |
|
Lianbio |
LIAN |
Director, 10% Owner |
|
0 |
2024-02-15 |
57,575,533 |
Premium* |
|
Acrivon Therapeutics, Inc. |
ACRV |
10% Owner |
|
0 |
2024-04-11 |
5,360,858 |
Premium* |
|
Chembio Diagnostics Inc |
CEMI |
Former 10% Owner |
2023-04-04 |
0 |
2023-04-27 |
0 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
10% Owner |
|
0 |
2023-06-06 |
2,207,753 |
Premium* |
|
Cargo Therapeutics, Inc. |
CRGX |
Former 10% Owner |
2023-11-14 |
0 |
2023-11-14 |
333,333 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
304 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 13
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2022-07-29 |
4 |
B |
$5.03 |
$1,117,279 |
I/I |
222,123 |
10,245,394 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2022-08-01 |
4 |
B |
$5.05 |
$728,134 |
I/I |
144,185 |
10,389,579 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2022-08-02 |
4 |
B |
$5.59 |
$2,305,350 |
I/I |
412,406 |
10,801,985 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2022-08-03 |
4 |
B |
$5.84 |
$584,000 |
I/I |
100,000 |
10,901,985 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2022-08-04 |
4 |
B |
$6.17 |
$586,767 |
I/I |
95,100 |
10,997,085 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2022-08-05 |
4 |
B |
$6.95 |
$979,950 |
I/I |
141,000 |
11,138,085 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2022-08-08 |
4 |
B |
$7.24 |
$702,280 |
I/I |
97,000 |
11,235,085 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2022-08-09 |
4 |
B |
$7.50 |
$750,000 |
I/I |
100,000 |
11,335,085 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2022-08-10 |
4 |
B |
$7.85 |
$117,750 |
I/I |
15,000 |
11,350,085 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2023-10-16 |
4 |
S |
$1.60 |
$3,920,000 |
I/I |
(2,450,000) |
8,900,085 |
0 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2023-10-18 |
4 |
S |
$1.74 |
$533,308 |
I/I |
(306,499) |
8,593,586 |
0 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2024-04-01 |
4 |
B |
$3.25 |
$27,216 |
I/I |
8,374 |
8,601,960 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2024-04-02 |
4 |
B |
$3.44 |
$640,015 |
I/I |
186,051 |
8,788,011 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2024-04-03 |
4 |
B |
$4.09 |
$1,267,274 |
I/I |
309,847 |
9,097,858 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2024-04-04 |
4 |
B |
$4.67 |
$655,112 |
I/I |
140,281 |
9,238,139 |
1.5 |
% |
|
ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
|
2024-04-05 |
4 |
B |
$4.74 |
$178,755 |
I/I |
37,712 |
9,275,851 |
1.5 |
% |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2014-05-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,339,444 |
|
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2016-12-01 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
15,876,947 |
|
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2016-12-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
13,223,947 |
|
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2017-07-13 |
4 |
B |
$12.25 |
$18,375,000 |
I/I |
1,500,000 |
17,888,597 |
1.5 |
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2018-03-01 |
4 |
B |
$13.69 |
$1,369,000 |
I/I |
100,000 |
17,988,597 |
1.5 |
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2018-03-02 |
4 |
B |
$13.90 |
$1,389,500 |
I/I |
100,000 |
18,088,597 |
1.5 |
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2018-03-05 |
4 |
B |
$13.56 |
$4,553,814 |
I/I |
335,827 |
18,424,424 |
1.5 |
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2018-09-12 |
4 |
B |
$12.00 |
$6,001,500 |
I/I |
500,000 |
20,524,424 |
1.5 |
- |
|
FOLD |
Amicus Therapeutics Inc |
10% Owner |
|
2018-09-13 |
4 |
B |
$11.74 |
$1,174,000 |
I/I |
100,000 |
20,624,424 |
1.5 |
- |
|
304 Records found
|
|
Page 3 of 13 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|